Nurse Practitioner · Los Angeles, CA
NPI
1447494679
Since 2009
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1441 Eastlake Ave, Nor 8302e
Los Angeles, CA, 90089
Phone (323) 865-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,192
136 services
Medicare patients, 2024
49
Average age 70
Drug cost, 2024
$1.3M
501 prescriptions
Company payments, 2025
$1,029
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tina Y Soo was code 99214 (office e&m - established), 78 times for 41 patients. In total Tina Y Soo billed 136 services in 6 codes, and Medicare paid $7,192.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 78 | 41 | $63.58 | $4,959 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 30 | 23 | $11.72 | $352 |
By year: 2022 $4,143 for 74 services; 2023 $9,423 for 143 services; 2024 $7,192 for 136 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tina Y Soo prescribed most often to Medicare patients was Imatinib Mesylate, with 79 prescriptions and refills. In total Tina Y Soo wrote 501 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 79 | 80 | Under 11 | $28K |
| Oxycodone Hcl Generic | 27 | 27 | Under 11 | $482 |
| Omeprazole Generic | 26 | 40 | Under 11 | $107 |
| Pantoprazole Sodium Generic | 25 | 41 | Under 11 | $219 |
| Ondansetron Odt Ondansetron | 21 | 21 | 11 | $269 |
| Lonsurf Trifluridine/Tipiracil Hcl | 21 | 21 | Under 11 | $224K |
| Xermelo Telotristat Etiprate | 20 | 20 | Under 11 | $191K |
| Ondansetron Hcl Generic | 19 | 19 | 11 | $722 |
| Tramadol Hcl Generic | 16 | 16 | Under 11 | $99.15 |
| Prochlorperazine Maleate Generic | 16 | 16 | 12 | $183 |
| Potassium Chloride Generic | 13 | 23 | Under 11 | $208 |
| Eliquis Apixaban | 12 | 14 | Under 11 | $8,576 |
| Synthroid Levothyroxine Sodium | 11 | 15 | Under 11 | $667 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 11 | 11 | Under 11 | $95.76 |
Brand drugs: 113 claims; generic drugs: 388 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tina Y Soo $1,029 ($1,029 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $284.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 11 | $284 |
| Eisai Inc. 4523.T | 6 | $168 |
| Syndax Pharmaceuticals, Inc. SNDX | 1 | $103 |
| Genzyme Corporation SNY | 2 | $68.52 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $63.46 |
| Daiichi Sankyo Inc. 4568.T | 2 | $50.78 |
| BeOne Medicines USA, Inc. ONC | 2 | $47.8 |
| Sobi, Inc SOBI.ST | 1 | $42.58 |
| Incyte Corporation INCY | 1 | $28.14 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $26.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.